论文部分内容阅读
目的探究亚临床甲状腺功能减退对冠状动脉粥样硬化性心脏病对于C反应蛋白(C-Reactive Protein,CRP)以及尿微量蛋白(microalbuminuria,MAU)的影响,并通过上述影响分析亚临床甲状腺功能减退与冠状动脉粥样硬化之间所存在的相关性进行讨论。方法入住我院的32例冠心病患者,分为A、B两组,即A组为冠心病合并亚临床甲状腺功能减退患者组,B组为冠心病无亚临床甲状腺功能减退患者组,每组为16例。对上述两组患者的如下几个方面的指标进行检测,即同型半胱氨酸(Hcy)、甘油三酯、总胆固醇、MAU以及CRP。结果 A组的指标值比B组均大,经计算,P<0.05,具有统计学差异。结论冠心病合并亚临床甲状腺功能减退在较大程度上影响患者的C反应蛋白以及尿微量蛋白的含量。
Objective To investigate the effect of subclinical hypothyroidism on C-Reactive Protein (CRP) and microalbuminuria (MAU) in patients with coronary heart disease (CHD) and to analyze the effects of subclinical hypothyroidism And coronary atherosclerosis exist between the relevance of the discussion. Methods A total of 32 CHD patients admitted to our hospital were divided into A and B groups, namely, group A with coronary heart disease and subclinical hypothyroidism, group B with CHD without subclinical hypothyroidism, and each group 16 cases. The two groups of patients in the following aspects of the indicators were detected, namely homocysteine (Hcy), triglycerides, total cholesterol, MAU and CRP. Results The index value of group A was larger than that of group B, and the difference was statistically significant (P <0.05). Conclusion Coronary heart disease combined with subclinical hypothyroidism in patients with a greater impact on C-reactive protein and urinary microalbumin content.